Interested in joining the team?

See our job openings

Our Advisors

Anita McGahan, PhD, MBA

Anita McGahan is a Professor of Strategic Management and George E. Connell Chair in Organizations & Society at Rotman (with a cross-appointment to the Munk School of Global Affairs). Her research is focused on industry change, sustainable competitive advantage and the establishment of new fields. An area of particular interest to her is in global health and the diffusion of knowledge across international boundaries.

Kalu-Kalu Ugwuomo, Jr.

Kalu-Kalu Ugwuomo, Jr is  Co-Founder of Nexus Africa, a  global network of African philanthropists, forming a strategic facet of the NexGen philanthropy network, Nexus Global and is currently the Director of International Relations at Abuja based Valley Agriculture and Foods Company. With over 10 years experience in International Development and Finance,  Kalu brings significant knowledge and expertise in philanthropy to business development across the African continent in a variety of different markets.  Kalu is a graduate of Howard University  and The United States Institute of Peace.

Sam Scarpino, PhD

Sam is an Assistant Professor in the Network Science Institute at Northeastern University–with appointments in Marine & Environmental Sciences, Physics, and Health Sciences (starting Sept. 2018)–and am the Chief Data Scientist at His research spans a broad range of topics in complex systems and network science, including: infectious disease dynamics, forecasting and predictive modeling, complex network analysis, disease genomics and transcriptomics, outbreak surveillance, social networks, gene network evolution, and decision making under uncertainty. Our group, the Emergent Epidemics Lab, approaches these topics by investigating questions using mathematical and computational methods from biology, statistics, physics, applied mathematics, and computer science.

Kenneth Gordon, JD

Ken Gordon is co-chair of the firm’s Technology practice. He has more than 25 years of experience representing privately held and publicly traded companies (domestic and foreign), investment banks and venture capital firms. Mr. Gordon concentrates his practice in the areas of general corporate representation, corporate finance and acquisitions.

Prior to becoming co-chair of the Technology  practice, Mr. Gordon held various other positions with the firm, most recently as National Hiring Partner. Mr. Gordon enjoys cycling and running and is an enthusiastic supporter of Boston sports teams. Mr. Gordon ran the 2014 Boston Marathon as part of a team which raised over $800,000 for the survivors of the 2013 Boston Marathon bombings.

Charles MaCormack, PhD

Charles MacCormack is currently the Senior Fellow for NGO Futures at Interaction, the national association of over 200 U.S. Humanitarian and Development organizations. He also serves as Vice Chair of the Millennium Development Goal Health Alliance. Throughout 2016 he served as an Advanced Leadership Fellow at Harvard University. He served as Executive-in-Residence at Middlebury College from 2012 to 2016, and works with a number of international think tanks.  Each of these activities advances knowledge, teaching and practice of the role of corporations, foundations, NGOs, universities, philanthropists and media in global health and development.

From 1993 through 2011, Professor MacCormack was president of Save the Children, the world’s leading independent nonprofit organization serving children in need.  With programs in the United States and more than 50 countries, an annual budget of over $550 million and more than 6,000 staff worldwide., Save the Children works to create lasting, positive change in the lives of children in need through programs in health care and nutrition, education and economic opportunity.  Save the Children also provides child-oriented humanitarian assistance during natural disasters, war and conflict.  He currently serves on the Board of Save the Children International, which programs more than $2.1billion in over 120 countries.

Pete Mooney, MBA

Pete retired as a Deloitte senior principal in 2017 after a successful thirty-five year career with the firm. He is a strategy consultant by background and has led a number of the firm’s most significant client relationships and cross-functional areas of practice globally.

Pete has worked almost exclusively in life sciences and health care for the last fifteen years, segueing into the industry though his work restructuring European process manufacturers in the mid-1990s. He was most recently Deloitte’s Global Managing Director for Life Sciences & Healthcare, growing the business over 35% to USD 2.5 billion in revenue during his tenure.

He has lived and worked outside of the U.S. for over 20 years, leading the firm’s European Manufacturing & Life Sciences industry practice and as CEO of the Netherlands consulting business, among other roles and client service. Pete has developed relationships with a broad range of senior executives and expertise in diverse developing markets such as Argentina, Brazil, China, and India, as well as Europe and America.

John Rosenblum

30 years Medical Software experience. Founder/CEO at Green Mountain Logic (acquired by PhaseForward ’07, Oracle ’10), VP LabPas Business Unit at Phase Forward, Senior Director of Strategy at Oracle Health Sciences. Currently John is CEO of Rosenblum Strategic and working with medical software startups.

John Canning

John founded the Physician’s Computing Company (PCC) at the age of 19 in 1982. After over 30 years, PCC is a nationally respected provider of pediatric management software with over 200 practices and offices across the country. John has donated his time to build the MEDSINC platform with expertise in JavaScript, HTML 5, SQL and Perl.

Bobby Jefferson

Bobby Jefferson currently serves as the Vice President and Chief Technology Officer for DAI Global Health. Bobby is a leader in the field of information and communications technology for development (ICT4D) and is working to expand DAI’s range of digital health services. Bobby has led a staff of health IT project managers, software engineers, and programmers to support countrywide health information systems for emerging markets. He has developed and deployed large-scale management information systems for use in international clinical trials and associated clinical data management.

Bobby most recently served as Vice President and Director of the Center for Development Informatics at Palladium (formerly Futures Group), where he built a practice focused on ICT for global health programs and adjacent sectors such as agriculture, supply chains, and education. Before joining Futures Group in 2006, he led a group at CTIS, Inc., that developed and implemented systems for managing large-scale clinical trials and associated data management. Prior to that, at SETA, Inc., he provided IT support to the U.S. Agency for International Development (USAID) in Russia, Georgia, and other eastern European countries.

Bobby is a member of the Drug Information Association and the Global Health Council, and serves on the board of the Prostate Cancer Network. He sits on various industry panels in the mobile health and digital development spaces, and serves as a competition judge and mentor with tech innovation hubs at Yale University, Duke University, and elsewhere.

Meredith Shields

Meredith is the Managing Director for the Sorenson Impact Foundation (SIF), which invests in innovative companies that are creating and scaling ideas to enhance social good around the world. Meredith manages the foundation’s impact investing portfolios and field building initiatives. She engages with social entrepreneurs and fund managers around the world who are working across the agriculture, technology, education, healthcare and retail sectors to develop solutions to the world’s most pressing social issues in a sustainable way. Prior to joining the Sorenson Impact Foundation, the majority of Meredith’s career was in investment banking and strategy consulting. She has also previously consulted to the Elizabeth Glaser Pediatric AIDS Foundation in both Rwanda and the U.S. as well as the Beyond Capital Fund, an early-stage impact investment fund, in Zurich, Switzerland. Meredith holds an MBA from the Kellogg School of Management at Northwestern University and a B.S. in Commerce from the University of Virginia’s McIntire School of Commerce.

Robert Gilman, MD

Dr. Robert Gilman is a professor of medicine at the Johns Hopkins University School of Medicine and a professor of international health at the Johns Hopkins Bloomberg School of Public Health. He also holds a joint appointment in molecular microbiology and immunology. His research focuses on disease control and has led to the development of microscopic-observation drug-susceptibility (MODS), a rapid tuberculosis diagnostic technique. He is currently engaged in ongoing infectious disease research based at the Universidad Peruana Cayetano Heredia in Peru. Dr. Gilman earned his M.D. from SUNY Downstate Medical College. He joined the Johns Hopkins faculty in 1991.

Prior to joining Johns Hopkins, Dr. Gilman worked with the U.S. Public Health Service and served as an assistant professor at the University of Maryland Hospital. He was also the chief of infectious disease at Wyman Park Hospital.

Sign up for THINKMD news